GRCL
Gracell Biotechnologies Inc.
NASDAQ: GRCL · HEALTHCARE · BIOTECHNOLOGY
$10.25
+0.00% today
Updated 2026-04-30
Market cap
$989.87M
P/E ratio
—
P/S ratio
732.21x
EPS (TTM)
$-0.97
Dividend yield
—
52W range
$307 – $525
Volume
6.4M
Gracell Biotechnologies Inc. (GRCL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-31.60%
ROA
-19.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-60.79M | — | — | — |
| 2019 | $0.00 | $-132.18M | — | — | — |
| 2020 | $0.00 | $-197.16M | — | — | — |
| 2021 | $366000.00 | $-465.88M | 100.00% | -126,659.29% | -127,289.62% |
| 2022 | $0.00 | $-607.51M | — | — | — |
| 2023 | $0.00 | $-496.98M | — | — | — |